Searchlight Pharma Inc. Sells to Apotex Inc.
Apr. 08, 2024 – Davies is acting for the shareholders of Searchlight Pharma Inc. (Searchlight) in connection with the sale of their 100% interest to Apotex Inc. (Apotex). Searchlight is a private, rapidly-growing Canadian company known for their innovative branded pharmaceuticals with a global reach that executes...
BELLUS Health Inc. Reaches Agreement for US$2-Billion Sale to GSK
Apr. 20, 2023 – Davies is acting as counsel to BELLUS Health, Inc. in its US$2-billion sale to GSK, a global pharmaceutical company headquartered in the United Kingdom. Based in Montréal, BELLUS Health works to better the lives of patients suffering from refractory chronic cough (RCC) that does not respond to...
123Dentist, Altima Dental and Lapointe Group Announce Strategic Merger
July 20, 2022 – Davies is acting as Canadian counsel to KKR, a leading global investment firm, in its equity investment in connection with the strategic merger between 123Dentist, Altima Dental and Lapointe Group. The merger will create one of the largest dental support organizations in Canada, with nearly 350...
Sixteen Davies Partners Recognized as Technology and Health Science Leaders
June 16, 2022 – Lexpert has named 16 Davies partners among Canada’s top practitioners in the 2022 Lexpert Special Edition: Technology and Health Sciences . A sampling of notable recent work includes advising Generac Holdings Inc., a leading energy technology company, in its US$770-million acquisition of ecobee...
Claridge Inc. Invests in Food Processing Innovation in Québec
Feb. 01, 2022 – Claridge Inc. has partnered with Investissement Québec and the Fonds de solidarité FTQ to create an investment vehicle to support Québec food processing companies that show significant growth potential. Davies acted for Claridge in the creation of the financial vehicle, with a target size of...
Nine Davies Lawyers Recognized as Leaders in Health Sciences
June 10, 2021 – Lexpert Magazine has named nine Davies partners among Canada’s top lawyers in its new 2021 Special Edition: Health Sciences . From biotech firms to medical device manufacturers, and private equity investors to pharmaceutical giants, we’ve worked with all industry players to help navigate the...
June 17, 2019 – Health Canada has released the final regulations (Regulations) that will govern cannabis edibles, extracts and topical products. The Regulations will come into force on October 17, 2019, in substantially the same form as the draft regulations published by Health Canada in December 2018. Market...
Ipsen Acquires Clementia Pharmaceuticals for US$1.3 Billion
Feb. 26, 2019 – Davies acted for French biopharmaceutical company Ipsen in the acquisition of Québec-based Clementia Pharmaceuticals for a purchase price of US$25. 00 per share in cash upfront, plus a contingent value right of US$6. 00 per share, for a total transaction value of up to US$1. 31 billion. The...
Hemp-Derived CBD: United States Liberalizes Regulation
Dec. 13, 2018 – While much of the focus recently has been on Canada’s recreational cannabis industry, the United States has made a progressive move of its own, approving legislation that will remove industrial hemp from the definition of “marihuana” under the federal Controlled Substances Act (CSA). The 2018 ...
Davies Welcomes New Partner Aaron Atkinson
Dec. 03, 2018 – Davies is pleased to announce that Aaron Atkinson has joined Davies as a partner in our Toronto office. Aaron brings nearly 20 years of experience advising clients across industry sectors in domestic and cross-border M&A transactions, corporate finance, capital markets and securities, and...
Davies Welcomes Michel Gélinas
Sept. 07, 2018 – Davies is pleased to announce that Michel Gélinas has joined the firm as a partner in our Montréal office. Michel’s practice focuses on advising clients on mergers and acquisitions, private equity, venture capital and corporate finance, both in Canada and internationally. “Michel’s reputation...
The Green Rush: The Cannabis Industry Rolls On
Aug. 03, 2018 – On October 17, 2018, the Canadian recreational cannabis market will open under a patchwork of federal and provincial legislation. With just over two months before legalization, the Canadian cannabis industry continues to evolve and grow at an unprecedented pace. We highlight significant...
Investment Considerations for the Cannabis Industry: Spotting the Red Flags
Nov. 22, 2017 – The recent $245-million investment by Constellation Brands, a NYSE-listed producer of beer, wine and spirits, in TSX-listed Canopy Growth focused attention across North America on the Canadian cannabis industry. The announcement of the approximately 9.9% investment on October 30, 2017 drove Canopy...
Québec Releases Framework for Recreational Cannabis
Nov. 21, 2017 – The Canadian government is going full steam ahead with its plans to legalize cannabis for recreational purposes in July 2018, but it has left some of the toughest decisions relating to the sale, distribution, cultivation and promotion of cannabis to the provinces and territories. As a result, a...
Forty-nine Davies Lawyers Recognized in Who’s Who Legal: Canada
Oct. 24, 2017 – Law Business Research’s Who’s Who Legal: Canada 2017 names 49 Davies partners as leading lawyers, including eight Most Highly Regarded practitioners, across 18 different practice areas. Who’s Who Legal nominees are selected on the basis of comprehensive, independent surveys conducted among...
Aug. 01, 2014 – Worldwide, regulators and courts are increasingly engaged in the complex legal and policy issues at the intersection of competition and patent regimes. Trolls, Hopping, Ambush and Hold-up: Emerging International Approaches to the Intersection of Competition and Patent Law surveys the state of...
